| Elizabeth R Lehner, MD | |
|
9900 Tamarack Rd, Woodbury, MN 55125-3609 | |
| (651) 471-5800 | |
| Not Available |
| Full Name | Elizabeth R Lehner |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 9900 Tamarack Rd, Woodbury, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174965172 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 61112 (Minnesota) | Primary |
| Entity Name | Healtheast Woodwinds Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356309322 PECOS PAC ID: 9638082563 Enrollment ID: O20031107000110 |
News Archive
The manufacturer of the experimental Ebola drug ZMapp says it has put other business on hold since August to boost production of the medication. Meanwhile, news outlets look at the government's authority to screen airline travelers, the House action to release additional funding for disease-fighting efforts and the Dallas hospital's defense of its treatment of the West African man who died of the disease this week.
Researchers from Boston University School of Medicine (BUSM) have shown that using magnetic resonance imaging (MRI) to measure blood flow over atherosclerotic plaques could help identify plaques at risk for thrombosis.
The first large-scale population-based study on the association between the SARS-CoV-2 vaccines and Bell's palsy confirms that the beneficial and protective effects of the vaccines far outweigh the risk of this rare adverse event.
Silence Therapeutics plc announces the issuance of United States patent 7,750,144, titled Methods and Compositions for Enhancing Efficacy and Specificity of RNA Silencing, by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of producing double stranded (RNAi) agents having decreased off-target silencing activity through certain structural modifications. The ability to minimize the off-target effects of RNAi therapeutics is critical for controlling unwanted cellular activity and/or potential safety concerns.
› Verified 6 days ago
| Entity Name | Healtheast Medical Research Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639125503 PECOS PAC ID: 3971407636 Enrollment ID: O20031124000507 |
News Archive
The manufacturer of the experimental Ebola drug ZMapp says it has put other business on hold since August to boost production of the medication. Meanwhile, news outlets look at the government's authority to screen airline travelers, the House action to release additional funding for disease-fighting efforts and the Dallas hospital's defense of its treatment of the West African man who died of the disease this week.
Researchers from Boston University School of Medicine (BUSM) have shown that using magnetic resonance imaging (MRI) to measure blood flow over atherosclerotic plaques could help identify plaques at risk for thrombosis.
The first large-scale population-based study on the association between the SARS-CoV-2 vaccines and Bell's palsy confirms that the beneficial and protective effects of the vaccines far outweigh the risk of this rare adverse event.
Silence Therapeutics plc announces the issuance of United States patent 7,750,144, titled Methods and Compositions for Enhancing Efficacy and Specificity of RNA Silencing, by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of producing double stranded (RNAi) agents having decreased off-target silencing activity through certain structural modifications. The ability to minimize the off-target effects of RNAi therapeutics is critical for controlling unwanted cellular activity and/or potential safety concerns.
› Verified 6 days ago
| Entity Name | Healtheast St Joseph's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134186273 PECOS PAC ID: 2365348869 Enrollment ID: O20031208000245 |
News Archive
The manufacturer of the experimental Ebola drug ZMapp says it has put other business on hold since August to boost production of the medication. Meanwhile, news outlets look at the government's authority to screen airline travelers, the House action to release additional funding for disease-fighting efforts and the Dallas hospital's defense of its treatment of the West African man who died of the disease this week.
Researchers from Boston University School of Medicine (BUSM) have shown that using magnetic resonance imaging (MRI) to measure blood flow over atherosclerotic plaques could help identify plaques at risk for thrombosis.
The first large-scale population-based study on the association between the SARS-CoV-2 vaccines and Bell's palsy confirms that the beneficial and protective effects of the vaccines far outweigh the risk of this rare adverse event.
Silence Therapeutics plc announces the issuance of United States patent 7,750,144, titled Methods and Compositions for Enhancing Efficacy and Specificity of RNA Silencing, by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of producing double stranded (RNAi) agents having decreased off-target silencing activity through certain structural modifications. The ability to minimize the off-target effects of RNAi therapeutics is critical for controlling unwanted cellular activity and/or potential safety concerns.
› Verified 6 days ago
| Entity Name | Healtheast St John's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447218482 PECOS PAC ID: 9234035742 Enrollment ID: O20031208000320 |
News Archive
The manufacturer of the experimental Ebola drug ZMapp says it has put other business on hold since August to boost production of the medication. Meanwhile, news outlets look at the government's authority to screen airline travelers, the House action to release additional funding for disease-fighting efforts and the Dallas hospital's defense of its treatment of the West African man who died of the disease this week.
Researchers from Boston University School of Medicine (BUSM) have shown that using magnetic resonance imaging (MRI) to measure blood flow over atherosclerotic plaques could help identify plaques at risk for thrombosis.
The first large-scale population-based study on the association between the SARS-CoV-2 vaccines and Bell's palsy confirms that the beneficial and protective effects of the vaccines far outweigh the risk of this rare adverse event.
Silence Therapeutics plc announces the issuance of United States patent 7,750,144, titled Methods and Compositions for Enhancing Efficacy and Specificity of RNA Silencing, by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of producing double stranded (RNAi) agents having decreased off-target silencing activity through certain structural modifications. The ability to minimize the off-target effects of RNAi therapeutics is critical for controlling unwanted cellular activity and/or potential safety concerns.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth R Lehner, MD 9900 Tamarack Rd, Woodbury, MN 55125-3609 Ph: (651) 471-5800 | Elizabeth R Lehner, MD 9900 Tamarack Rd, Woodbury, MN 55125-3609 Ph: (651) 471-5800 |
News Archive
The manufacturer of the experimental Ebola drug ZMapp says it has put other business on hold since August to boost production of the medication. Meanwhile, news outlets look at the government's authority to screen airline travelers, the House action to release additional funding for disease-fighting efforts and the Dallas hospital's defense of its treatment of the West African man who died of the disease this week.
Researchers from Boston University School of Medicine (BUSM) have shown that using magnetic resonance imaging (MRI) to measure blood flow over atherosclerotic plaques could help identify plaques at risk for thrombosis.
The first large-scale population-based study on the association between the SARS-CoV-2 vaccines and Bell's palsy confirms that the beneficial and protective effects of the vaccines far outweigh the risk of this rare adverse event.
Silence Therapeutics plc announces the issuance of United States patent 7,750,144, titled Methods and Compositions for Enhancing Efficacy and Specificity of RNA Silencing, by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of producing double stranded (RNAi) agents having decreased off-target silencing activity through certain structural modifications. The ability to minimize the off-target effects of RNAi therapeutics is critical for controlling unwanted cellular activity and/or potential safety concerns.
› Verified 6 days ago
Dr. Bridgette Marie Suri, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8450 Seasons Pkwy, Woodbury, MN 55125 Phone: 651-702-5300 | |
Alicia Marie Osterman Kemp, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8450 Seasons Pkwy, Woodbury, MN 55125 Phone: 651-702-5300 Fax: 651-702-5305 | |
Michele L Peterson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1875 Woodwinds Dr, Woodbury, MN 55125 Phone: 651-232-6700 Fax: 651-232-6711 | |
Chelsey Prall, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 8450 Seasons Pkwy, Woodbury, MN 55125 Phone: 651-702-5300 Fax: 651-702-5305 | |
Sara K Sweetser, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7803 Afton Rd, Woodbury, MN 55125 Phone: 651-738-0470 Fax: 651-738-8915 | |
Dr. Jennifer M.h. Mccormack, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8450 Seasons Parkway, Healthpartners Woodbury Clinic Ms 32900a, Woodbury, MN 55125 Phone: 651-702-5300 Fax: 651-702-5305 | |
Margaret Kelly Tierney, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9680 Tamarack Rd Ste 100, Woodbury, MN 55125 Phone: 651-738-0470 |